Venus Remedies informs about press release

20 Sep 2023 Evaluate

Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies extends Its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Venus Remedies Share Price

818.15 33.50 (4.27%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×